Siegfried Reich

Insider Reports History

Location
San Diego, CA
Signature
/s/ Paolo Tombesi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Siegfried Reich:

Company Role Class Num Shares Value Price $ Report Date Ownership
Turning Point Therapeutics, Inc. EVP & Chief Scientific Officer Common Stock 17,015 $1,293,140 $76.00 09 Feb 2022 Direct
Turning Point Therapeutics, Inc. EVP & Chief Scientific Officer Stock Option (right to buy) 48,833 09 Feb 2022 Direct

Insider Reports Filed by Siegfried Reich

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919122008984-reich-siegfried-2022-02-09 Turning Point Therapeutics, Inc. 09 Feb 2022 3 -$14,411 4 EVP & Chief Scientific Officer 11 Feb 2022, 17:10